Are you under 30 35 and ready to prove your expertise in Atopic Dermatitis? The RAJKA-ISAD Symposium is calling all residents, fellows, and early-career practitioners (ECP) to step out of the clinic and into the arena. We are launching “The AD Masterminds”—a high-stakes, high-energy team tournament designed to crown the future leaders of AD care. […]
Read MoreA New Chapter in International Partnership The International Society of Atopic Dermatitis (ISAD) is pleased to announce the establishment of a The International Society of Atopic Dermatitis (ISAD) and the European Academy of Allergy and Clinical Immunology (EAACI) are proud to announce a formal strategic partnership, cemented by a Memorandum of Understanding signed in February […]
Read MoreBeyond the “All-TH2” Paradigm in Atopic Dermatitis For more than two decades, atopic dermatitis (AD) has largely been interpreted through the framework of type-2 immunity. IL-4, IL-13, IgE, and eosinophils became the canonical pathway explaining disease pathogenesis and guiding therapeutic development. The remarkable clinical success of IL-4/IL-13 blockade has reinforced this paradigm. Yet both the […]
Read MoreAPPLY BEFORE APRIL 15! (extended) Are you an early-career dermatologist or researcher in epidemiology or public health? The ISAD-GADA Fellowship offers the chance to work with the Global Atopic Dermatitis Atlas (GADA) team, develop key research skills, and lead a small research project! The GADA team will provide state-of-the-art training in epidemiological research methodology, guiding […]
Read MoreAI-Powered Atopic Dermatitis Assessment: Patients Can Contribute + Small punch biopsies and non-negative matrix factorization (NMF) to study AD transcriptome + An important role of IL-22 in Th2 driven acute AD in epidermal reconstructs models + Health-Related Quality of Life in AD and Psoriasis: Are There Distinct Psychological Traits? + Towards a scientific approach of traditional Chinese medicine formulas
Read MoreThe ISAD–WHO course on atopic dermatitis in Black skin is now available, in addition to the WHO Academy platform, on the newly launched ILDS Skin Health Training Hub. Atopic Dermatitis with focus on Sub-Saharan Africa: Training for national and district-level health workers To access the course, you can either use this link https://whoacademy.org/ or type the […]
Read MoreSave the date! March 30, 08:00 – 09:30 am Denver Time (MDT, UTC-6), via ZoomZürich time (CEST, UTC+2): 16:00 – 17:30Duration: 90 minutes Introduction The ISAD-OPENED Task Force will hold its first biannual meeting of 2026 during the AAD Congress in Denver, Colorado. Following a survey conducted among our members, this meeting will be held […]
Read MoreCongratulations to Erere OTROFANOWEI and colleagues for this important multi-country study on the accessibility and affordability of emollients for atopic dermatitis in Africa, now published in Journal of Investigative Dermatology. Their survey across 16 mostly Sub-Saharan African countries highlights a crucial but often overlooked reality: even basic moisturizers—the foundation of atopic dermatitis management—remain financially out […]
Read MoreThe Ethics of Prescribing and Access in Atopic Dermatitis: Can We Separate Them? Therapeutic innovation in atopic dermatitis (AD) has advanced rapidly. Biologics and targeted therapies have transformed the outlook for patients with severe disease. Yet a central ethical tension is emerging: what is the value of prescribing the best treatment if patients cannot access […]
Read MoreProf Kin Fon LEONG from Malaysia kindly shares his book with the ISAD community — many thanks! Two educative booklets from Malaysia Fore word Dr Yong Kwang TAY, FRCPSingapore
Read More